For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluorescence imaging, and other visualization processes to get quantitative data from cell populations.
According to our (Global Info Research) latest study, the global High Content Screening market size was valued at USD 579.9 million in 2022 and is forecast to a readjusted size of USD 992.9 million by 2029 with a CAGR of 8.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The high-content screening market is anticipated to witness significant growth during the forecast period, owing to the ability of HCS to study several parameters in a complex biological system simultaneously.
This report is a detailed and comprehensive analysis for global High Content Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global High Content Screening market size and forecasts, in consumption value ($ Million), 2018-2029
Global High Content Screening market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global High Content Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global High Content Screening market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High Content Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global High Content Screening market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Molecular Devices, Thermo Fisher Scientific, PerkinElmer Inc., Becton and GE Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
High Content Screening market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Consumables
- Microplates
- Instruments
- Software and Service
Market segment by Application
- Primary & Secondary Screening
- Compound Profiling
- Target Identification & Validation
Market segment by players, this report covers
- Molecular Devices
- Thermo Fisher Scientific
- PerkinElmer Inc.
- Becton
- GE Healthcare
- Dickinson and Company
- Merck KGaA
- Cell Signaling Technology
- Thorlabs, Inc.
- Genedata AG
- Yokogawa Electric Corporation
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe High Content Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of High Content Screening, with revenue, gross margin and global market share of High Content Screening from 2018 to 2023.
Chapter 3, the High Content Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and High Content Screening market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of High Content Screening.
Chapter 13, to describe High Content Screening research findings and conclusion.